Tuesday, January 30, 2018 10:15 PM ET
Significant Insider purchase Extends the buy Trend of Last 90 Days in Shares of Kala Pharmaceuticals (KALA)
There was substantial purchase activity in Kala Pharmaceuticals shares by an insider today, as revealed in a form 4 document filed with the SEC. One insider — OrbiMed Advisors Llc, 10% Owner — bought 72,760 shares in the company having a market value of approximately $1,089,307. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 497,769 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 570,529 shares and have averaged 285,265 shares per transaction over this time period.
During the last 90 days, the number of insider buy/sell trades at Kala Pharmaceuticals is higher than the 280-company peer group average. Bio Therapeutic Drugs peer group saw 326 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Kala Pharmaceuticals insiders was also higher. Within the peer group there were 33,192,513 shares purchased and 42,977,762 shares sold with company insiders selling 30,016 shares on average.
In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated data obtained to evaluate and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.